MEDREGEN

Clinical stage pharmaceutical company

  • Home
  • About Us
    • Company Overview
    • Company History
    • Our Mission
  • Scientific Approach
    • Immunoregulatory and Regenerative Therapy
    • Publications
  • Pipeline
    • Pipeline Overview
    • MRG-001
    • MRG-002
    • Expanded Access (MRG-001)
  • News
  • Contact Us

Posts classified under: Incubator

MedRegen LLC   →  Incubator
MEDREGEN

MedRegen is a clinical stage pharmaceutical company developing novel therapeutics for the treatment of different types of organ and tissue injury.

Useful Links

  • Pipeline
  • Publications
  • News
  • About Us
  • Contact Us

RECENT POST

  • Phase II ARDS IND Submission China (NMPA) October 30, 2024
  • Phase II Wound Healing Study Completed September 14, 2024
  • FDA Phase II IND Approval (ARDS) May 3, 2024
© 2024 MedRegen LLC. All rights reserved.
  • Privacy Policy
  • Terms of Use